Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VRAY

ViewRay (VRAY) Stock Price, News & Analysis

ViewRay logo

About ViewRay Stock (NASDAQ:VRAY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.03
$0.65
52-Week Range
N/A
Volume
108.50 million shs
Average Volume
7.51 million shs
Market Capitalization
$4.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.

VRAY Stock News Headlines

ViewRay Inc (VRAYQ) Earnings Dates & Reports
VRAY Jan 2025 2.000 call
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
VRAY Jan 2025 0.500 put
VRAY Jan 2025 0.500 call
VRAY Jan 2025 3.000 put
ViewRay Inc VRAYQ
NUBURU Appoints Brian Knaley as new CEO
See More Headlines

VRAY Stock Analysis - Frequently Asked Questions

ViewRay, Inc. (NASDAQ:VRAY) posted its quarterly earnings data on Monday, February, 27th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.01. The company's revenue was up 70.1% compared to the same quarter last year.

ViewRay subsidiaries include these companies: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..

ViewRay (VRAY) raised $52 million in an initial public offering on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ViewRay investors own include Alibaba Group (BABA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), NVIDIA (NVDA), Bristol Myers Squibb (BMY) and Amarin (AMRN).

Company Calendar

Last Earnings
2/27/2023
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VRAY
CIK
1597313
Employees
295
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
($0.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$107.33 million
Net Margins
-104.30%
Pretax Margin
-104.30%
Return on Equity
-120.48%
Return on Assets
-42.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.16
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$105.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
183,402,000
Free Float
178,817,000
Market Cap
$4.59 million
Optionable
Optionable
Beta
0.81

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:VRAY) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners